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to be el ¢01%-~m. Reran1 sludies have shown the bon~fic~RI effect of beta 
radiation m ~'roventmg smoolh muscle coil proliferation following ang~opla.~ty 
and stem plaeemem Radioactive gold Au 198 (h~llhfo 27 d, 096 MeV) 
might b~ useful aa a beta soumo stnce it may interaCt Io~s with endothelial 
cell ~r0wlh  duo ~o ~fs short hnlt hfn. Th~s study mvostlgat0~ the effect Of 
dtfforeof (t0ses Of Au 198 gold coated slants on neointimal prolifemhon in the 
an!n~l model 
Methods. Got¢3 coated (5 ~m) stmnless steel stents (InFlow Dynam;cs, 
Munich, C~m~ny) were ac11vale~ in the neutron I~am of a nuc le i  reactor 
Stent a~31~vffms wero prock=¢ed to tall into ~ (JOSe qategones ranging from 0 
Gravy (Gy) 1o ~0 Gy. Th~r~*-s=x stems were random;~, implanted m the Coronary 
adeees 01 t8 min~p~ Iof~avascular ultrasound (!VU,~) was Pe~0med at 4 
weeks, fl!slomoq~homeln/and repeat IVUS wd! be per to~ at t2 weeks 
Resutt~.: lmp4anfatlons of the g~l  stems were successful with no acum 
complications. C~e~tmtqh based on the !VUS =ndioaled nO s~gniticant d~t. 
fe re~ b#~n the eye,stretch on the comml and mdiwdua! (:toses~ The 
bttnded !VUS iovesl~gat~on at 4 weeks ~r',(/ioa*es a ~ose ~pendem effect On 
~=~,o(fltilTt~l prehte,at~On 
" " p<Ol l l  v.~ ¢'oalrtil 
II 
L'ontro| t).2 1|.h5 2.2 h.7 20 Gy 
Cof"~ch~on: These 4 week IVUS data md~cate a s~gnd~can! reduction of 
neomt~mal ceil grewzh t~r~j  ~p~t~n at a Au198 coateO ra~oact~e 
stent. 12 week IVUS and histo/'norphometnc resutts w~i| be reported a'~ well 
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Backgtour~.- In pre~'~ou~ ~tt.~e~ we have shown ta',~ora..~te rasu~ after aural- 
ogo~s vein graft-coated stent (AVGCS) ;mp{antat~on = ar~rnals (JACC 1996: 
28. 1(~,~9-1046]. Th~s Is the first report of the immediate and long-term results 
of AVGC$ fmplantat~n tn 51 patients (pts). 
P.fethods: A 3-4 cm vein graft was removed ~ the nght cephat~c vein 
A stent was either covered comp~teh/both extemaih/ar~J internally (type A) 
oc only extematty (type B) by the g~ft A Palmaz ", a Palmaz-Schatz" or a 
Mu~lmk" stent was used for the procedure The veto hmng was stab~hzed 
on the stent by sutures (Prolene 7-Oy F~by-three AVGCSs It0 ~ype A. 43 
type B) were implanted in 51 pt~ (59 : 8 yrs) tar the tallowing indications: 16 
AVGCSs in elective les~ns, 7 in astral lesions, 6 ~n totally occluded vessels. 
10 far treatment of acute ~rdta l  intarct~on (AMI). 7 =n by-pass vein grafts. 
and 7 as a bail-out ~ .  
ResuttS: The AVGCS preparation was feasible and short ~n durahon (- 20 
m~n) to~" both tyl~es. No case of thror~J~os~s was obser~ecL except o~e patient 
who presented with subacute thrombosis 20 days after the procedure. The 
minimal luminal diameter (MLD) was increased tram 0.33 ± 0.33 mm to 322 
~- 0 48 mm (n = 53. p ° 0.0OI ). Two pLs required a repeat ang~oplasty and 
2 pts underwent non-emergency coronary by-pass surgery. Neither death 
nor myocardial infarction was reported dunng the follow-up period In 21 pts 
(23 lesions), mctuding the pts wdh chnical restenos=S, an ang~ography was 
performed after 7.5 ± 2 months (MLD immediately after: 316 ± 0.39, MLD 
folloW-UD: 2.26 ~ 0.54 mm). The event-free survival ~ate at 2 years tallow-up 
was 89% ~Gr~ph). 
; . . . .  
F-allow.u0 (morM~l 
Conc/usion: The chnical expenence by using the AVGCS was encouraging 
regarding the acute and long-term results. Large randomized rnutticenter 
studies are warranted to show the clinical value of this type of stent. 
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Background: Expenmental Stuc!nes from Our mst~tuhon here, fm(~n tavo~a¢~e 
results of the autologous artena! graft~co~ted stont (AAGCS) implanlation 
~n pomme coro~a~/ stlenes, This iS the fir~.t report el th~ Im~iate  She 
follow-up r~gffS 0f AAGC~ Implantation !n 15 palmnts [pls=), 
Methods: After gefformmQ Allen's lest a 3--4 cm grail w~ harveste<l from 
the tell radial artery and cleared from the bounOaq/tissues, A pre~nO~nted 
Muttibnk" stem was covered exlematly by the arlena! graft, wh,:h was ~-  
bd,zed on the stem I~y 3 sutures (Prolene 7,0) at each end (figure). F inn  
AAGCSs were implanted m 1,5 pls (55 ± ? ym). Nine AAGCSs were placed m 
sapheno~s veto grafts, 5 ,n elective les~ons, and I in o~itlal lesion. All pts left 
hosp~tat uncte~ aspmn ancl t~cloptdine and they were scheduled for treadmill 
Resut*.~: The procedure of stent coating was teas~bte and short in duration 
{<20 m~n~, w~'mut compftcafm~s. The min~nal uminal diameter (MID) was 
increased from 0.47 ± 0215 to 3.06 ~ 0~'~ mm (n = 15, p < 0.001). NO case 
of thremloos~$ was at, served and all pts were d, scharged wrtho~t symptoms. 
At! pts r~d negat~e TST, e~cept o~e w~h recurrence of symplorn~ afler 3 
months. In 9 pts an ang~grapr'~ was performed after 6,12 ± 1.11 months 
(MLD ~mmed~tety after: 3.09 ~ 0.51 mm, tallow-up: 2.39 ± 0%3 mm, n = 9, 
p = NS). 
Conctus~on: The preliminary results by using the AAGCS were encourag- 
=n 9 regardm 0 the feasibility and the thrombosis and restenosis rate. Large 
multfcenter studies are needed to it~cate rite clinical value at th~s new type 
of COated slant. 
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Pefcutaneous c~ret~ary dnten,,entJon fs currently used to tn~t coronary ath- 
erescteresla but is plagued by restenosm. We hypcthes~ze thai a stent vv~h 
integrated r,~crofabncated probes (fig. 1 ), can produce co~rolied inc~slons 
~rcugh atherescferot~c plaque enabling me detrvery of t~gh concer~ra~ion 
drug or gone therapy. Three sets of m~crofabrcated probes (65 ± 15, 120 ± 
20. and 185 = 25 ~,ml were deployed in normal and atherosclerctic 
Eltac artery segments (n = 5 eaCh) under physroIog=c dzsten~on at pressures 
of t00, 300, and 500 mmHg to s~mulate post-stent,~J conditions. The tissues 
were fixed white the pmt~s romarne~ in ptace and analyzed us,rig SEM. 
TEM. and hum m~crescopy to evaluate the extent and nature of vessel pen- 
et~tlon Figure 2 shows how n~,3~o~;,o~ produce controlled incisions in 
the artenal wall. 
Microprobes are able to p~erce the internal elastic lamina and penetrate 
the media, with the h~ghest probes neady reaching the media/advent~ba 
boundary. Th~s data suggests that a microprobe-studded stent can achieve 
COntrolled incisions into the a."tenal wall and may facilitate the clelrvery of 
therapeutiCS beyond atherosclerotic plaque. 
